Abstract

Study aim was to describe the variation of real-world treatment patterns by race among metastatic hormone sensitive prostate cancer (mHSPC) patients treated at five community cancer centers in the US.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis.
Takafumi Yanagisawa ... Fahad Quhal
Investigative urology | VOL. 210
Takafumi Yanagisawa, et. al.Takafumi Yanagisawa ... Fahad Quhal
20 Jun 2023
Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer.
Nieves Martinez Chanza ... Spyridon Sideris
Prostate cancer and prostatic diseases | VOL. 25
Nieves Martinez Chanza, et. al.Nieves Martinez Chanza ... Spyridon Sideris
09 Jun 2021
Lower baseline testosterone level is related to earlier development of castration resistance in metastatic prostate cancer: a multi-center cohort study.
Ho Ming Chris Wong ... Isabel Heidegger
Frontiers in Oncology | VOL. 14
Ho Ming Chris Wong, et. al.Ho Ming Chris Wong ... Isabel Heidegger
20 Feb 2024
Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination Therapies.
Mike Wenzel ... Marit Ahrens
Frontiers in Oncology | VOL. 11
Mike Wenzel, et. al.Mike Wenzel ... Marit Ahrens
23 Apr 2021
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
EQ-5D-5L population scores in mainland China: results from a nationally representative survey 2021
Qiang Yao ... Chaojie Liu
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Qiang Yao, et. al.Qiang Yao ... Chaojie Liu
06 Jul 2024
View more papers